NCT00767052 - Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Study Completion Date

December 31, 2008

Conditions

Healthy Volunteer

Interventions

DRUG

AZD1236

75mg once daily or 75mg twice daily will be administered in multiple dose part.

DRUG

Placebo

Placebo tablet matching to the active in multiple dose part.

DRUG

AZD1236

75mg single dose will be administered in relative bioavailability part.

DRUG

AZD1236

75mg oral suspension single dose will be administered in relative bioavailability part.

Trial Locations (1)

Research Site, Osaka